Company intelligence / Profile preview
Strassenburg Pharmaceuticals
- Ownership
- Private
- Employees
- ~501
- Development stage
- Other
Overview
Strassenburg Pharmaceuticals markets a portfolio of generic small molecule drugs in India for pain, fever, respiratory, GI, infectious, and nutritional conditions; there are no pipeline innovative or novel clinical-stage products identified[3][9].
- Therapeutic areas
- Infectious DiseasesGastroenterologyHematologyPulmonologyNeurology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Strassenburg Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Strassenburg Pharmaceuticals.